Superiority of Ferumoxytol MRI Over Pre-Contrast Imaging in Patients With Malignant Brain Lesions
This study provides robust evidence that ferumoxytol-enhanced MRI improves lesion visualization compared to pre-contrast imaging. Ferumoxytol as an MRI contrast agent in brain tumor imaging may provide a valuable clinical alternative to gadolinium-based contrast agents in appropriate patient groups.
Authors
- Edward A. Neuwelt (ORCID: https://orcid.org/0000-0002-6679-6203)
- László Szidonya (ORCID: https://orcid.org/0000-0002-5687-7835)
- William Strauss (ORCID: https://orcid.org/0000-0003-2840-3381)
- AMY M. HUDDLESTON
- Dana Branton
- Lisa Muir
- Rongwei Fu
Institutions
- Oregon Health & Science University (US)
Publication Details
- Journal
- American Journal of Neuroradiology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3174/ajnr.a9172
- Primary Topic
- Lanthanide and Transition Metal Complexes
- Type
- article
- Field-Weighted Citation Impact
- 0.00